Camillo Ricordi, MD, is an internationally recognized scientist and surgeon, best known for developing the groundbreaking method to isolate insulin-producing islet cells from the human pancreas—a discovery that revolutionized diabetes research and treatment. He has served at leading institutions including Washington University, the University of Pittsburgh, and since 1993, the University of Miami, where he is Professor of Surgery and Director of the Cell Transplant Center. Ricordi has led pioneering advances in cell transplantation, regenerative medicine, and clinical trials, including the first successful bioengineered pancreas implants and landmark studies in islet transplantation. He also spearheaded innovative cell-based therapies for autoimmune diseases and severe COVID-19, achieving unprecedented survival outcomes. Over his career, Ricordi has authored more than 1,200 scientific publications, holds 28 patents, and has received numerous international awards, including the World Prize in Surgery, induction into the Association of American Physicians, the National Academy of Inventors, and knighthood from the President of Italy. He continues to lead global collaborations, chair international trials, and advise governments, foundations, and biotech companies. Widely regarded as the world’s leading expert in islet transplantation, Ricordi remains at the forefront of efforts to cure diabetes, extend healthy lifespan, and advance regenerative medicine worldwide.